Q3 2024 Holdings
Filed 2024-11-14 | 87 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $88.9M | 900,000 | 6.9% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $80.1M | 8,528,500 | 6.2% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $59.3M | 2,534,540 | 4.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $51.9M | 6,223,544 | 4.0% |
| Axogen Inc(AXGN) | COM | 05463X106 | $42.1M | 3,005,943 | 3.3% |
| Grifols S A(GRFS) | SP ADR REP B NVT | 398438408 | $40.2M | 4,521,703 | 3.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $39.5M | 216,979 | 3.1% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $37.6M | 6,603,996 | 2.9% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $36.5M | 101,894 | 2.8% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $35.3M | 612,000 | 2.7% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $33.9M | 11,839,876 | 2.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $33.2M | 1,049,314 | 2.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $32.0M | 704,584 | 2.5% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $31.3M | 686,000 | 2.4% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $26.0M | 4,288,167 | 2.0% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $25.3M | 1,343,665 | 2.0% |
| Surmodics Inc(SU6) | COM | 868873100 | $24.7M | 637,698 | 1.9% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $23.9M | 1,065,834 | 1.9% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $21.5M | 951,000 | 1.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $21.0M | 1,090,984 | 1.6% |
| Merus N V | COM | N5749R100 | $19.9M | 398,321 | 1.5% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $18.9M | 662,332 | 1.5% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $18.6M | 7,309,254 | 1.4% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $18.6M | 82,750 | 1.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $18.6M | 1,245,387 | 1.4% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $17.1M | 19,300 | 1.3% |
| Neuropace Inc(NPCE) | COM | 641288105 | $17.0M | 2,433,168 | 1.3% |
| Evolus Inc(EOLS) | COM | 30052C107 | $16.8M | 1,037,680 | 1.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $16.3M | 59,400 | 1.3% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $16.0M | 269,000 | 1.2% |
| Elevance Health Inc(ELV) | COM | 036752103 | $15.4M | 29,650 | 1.2% |
| Rigel Pharmaceuticals Inc(RIGL) | COM | 766559702 | $15.1M | 934,788 | 1.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $14.9M | 259,398 | 1.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $13.0M | 224,600 | 1.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $12.9M | 340,585 | 1.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $12.0M | 7,293,007 | 0.9% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $11.6M | 1,424,000 | 0.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $11.1M | 598,169 | 0.9% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $10.6M | 318,269 | 0.8% |
| Orthofix MED Inc(OFIX) | COM | 68752M108 | $9.5M | 606,933 | 0.7% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $8.5M | 2,827,963 | 0.7% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $8.1M | 785,546 | 0.6% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $7.8M | 288,945 | 0.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $7.8M | 93,031 | 0.6% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $7.6M | 74,357 | 0.6% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $7.6M | 302,500 | 0.6% |
| Biodesix Inc | COM | 09075X108 | $7.2M | 4,038,065 | 0.6% |
| Takeda Pharmaceutical Co LTD(TAK) | SPONSORED ADS | 874060205 | $7.1M | 500,000 | 0.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $6.4M | 910,000 | 0.5% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $6.2M | 285,000 | 0.5% |